Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Karolinska Institutet
- SciLifeLab
- ;
- Aix-Marseille Université
- Ghent University
- IEMN CNRS Université de Lille
- INSERM U1312-Bordeau University
- LIPHY UMR5588 CNRS Univ. Grenoble Alpes
- Medical University of Lodz
- Monash University
- Radboud University Medical Center (Radboudumc)
- Slovak University of Agriculture in Nitra
- University of Salzburg
- Uppsala University
- Uppsala universitet
- Utrecht University
- 6 more »
- « less
-
Field
-
the presence of a cancer cell immobilized on the chip by quantum-tunneling current fluctuations. Experimental studies are complemented by two key theoretical and computer modeling pillars: extensive all-atom
-
study plan. For a doctoral degree, the equivalent of four years of full-time doctoral education is required. The research group Join us in advancing precision cancer medicine! Our lab is pioneering deep
-
an individual study plan. For a doctoral degree, the equivalent of four years of full-time doctoral education is required. The research group The doctoral studies will be conducted in the Cancer proteomics Mass
-
is integrated in the Center of Cancer Research of Marseille (Inserm U1068, CNRS UMR7258, Aix-Marseille Université UM105, Institut Paoli-Calmettes) and located in the La Timone Health Science campus
-
our interest is how xenobiotics might modulate the function of both cancer and normal cells. Currently, we are focused on the effect of mycotoxins- a toxic metabolites of fungi on hormone sensitive
-
, translational, and clinical research and educational activities related to cancer are carried out. Approximately 300 people from over 40 nations are currently working in the department. About 30 research groups
-
-maladies-cutanees-rares/ ) is seeking to recruit a new JuniorResearcher to develop innovative research programs on the biology and treatment of skin cancer. Labelled INSERM TRIO2 team, which works on skin
-
biomedical science. The department is among the largest of its type in Europe and has especially strong research profiles in psychiatric, cancer, reproductive, pediatric, pharmaco, genetic, and geriatric
-
cancer diagnostics and treatment This project will be conducted in interdisciplinary collaboration between MIDA group and researchers at the Department of Immunology, Genetics and Pathology (IGP
-
molecular and temporal resolution. Addressing this challenge will illuminate our understanding of disease development e.g. cell signalling in cancer or aggregation in amyloid disease and provide starting